A methodological note on the CYP-guides randomized controlled trial for the treatment of major depression
Genetically guided therapy for major depression has been recently recommended but has resulted in null effects. We hypothesized that a potential confounding variable for not finding differences in Length of Stay and Re-admission rate in a major depression clinical trial is the equivalence between tr...
Main Authors: | Georgios Sideridis, Ghadah Alkhadim |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-10-01
|
Series: | Frontiers in Psychiatry |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fpsyt.2022.888065/full |
Similar Items
-
Predictors of Treatment Response and Length of Stay for Inpatients with Major Depression
by: I-Chih Cheng, et al.
Published: (2007-11-01) -
Sub-Analysis of CYP-GUIDES Data: Assessing the Prevalence and Impact of Drug-Gene Interactions in an Ethnically Diverse Cohort of Depressed Individuals
by: Rustin D. Crutchley, et al.
Published: (2022-04-01) -
Clinical database of the CYP-guides trial: An open data resource on psychiatric hospitalization for severe depression
by: Joseph Tortora, et al.
Published: (2020-06-01) -
Appropriateness of hospital admission and length of stay in the pediatric department of a tertiary care hospital in West Bengal
by: Sampriti Samanta, et al.
Published: (2023-01-01) -
Major Depressive Disorder prolongs hospital stay among hospitalizations with Opioid Use Disorder
by: Adeolu Funso Oladunjoye, et al.
Published: (2023-06-01)